CVR: 44083205
Secondary names: Serprozyme Pharmaceuticals Aps, Serprozyme Bio ApS, Serprozyme Danmark ApS
Serprozyme ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kristian Jensen. The company is owned by Emvijo Initiative ApS and Jan Kristian Jensen Holding ApS. In 2025, the company reported a gross profit of DKK 168,506 and a net result of DKK 131,445 compared with DKK 24,507 the year before. Equity amounted to DKK 193,766.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med handel og service, samt enhver i forbindelse hermed stående virksomhed.
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Serprozyme ApS has published its annual report for 2025. Gross profit came to DKK 168,506, and the net result was DKK 131,445.
Serprozyme ApS has published its annual report for 2024. Gross profit came to DKK 31,033, and the net result was DKK 24,507.
Serprozyme ApS has published its interim report for the period May 26, 2023 – December 31, 2023.
As of May 26, 2023, Jan Kristian Jensen is registered as adm. dir. of Serprozyme ApS.
As of May 26, 2023, Emvijo Initiative ApS is registered as an owner of Serprozyme ApS with an ownership share of 50%.
As of May 26, 2023, Jan Kristian Jensen Holding ApS is registered as an owner of Serprozyme ApS with an ownership share of 50%.
Serprozyme ApS was founded on May 26, 2023.
Companies in the same industry and area
CVR 20110007
CVR 43257706
CVR 21826804
CVR 30521641
CVR 37493678
companydata.dk